Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/190755
Title: The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity
Author: Latorre, Jèssica
Martínez, Cristina
Ortega, Francisco
Oliveras-Cañellas, Núria
Díaz-Sáez, Francisco
Aragonés, Julian
Camps Camprubí, Marta
Gumà i Garcia, Anna Maria
Ricart, Wifredo
Fernández-Real Lemos, José Manuel
Moreno-Navarrete, José María
Keywords: Teixit adipós
Obesitat
Adipose tissues
Obesity
Issue Date: 9-Nov-2022
Publisher: Elsevier Masson SAS
Abstract: Objective: To investigate the potential role of EGFR, ErbBs receptors and neuregulins in human adipose tissue physiology in obesity. Methods: Gene expression analysis in human subcutaneous (SAT) and visceral (VAT) adipose tissue in three independent cohorts [two cross-sectional (N = 150, N = 87) and one longitudinal (n = 25)], and in vitro gene knockdown and overexpression experiments were performed. Results: While both SAT and VAT ERBB2 and ERBB4 mRNA increased in obesity, SAT EGFR mRNA was negatively correlated with insulin resistance, but did not change in obesity. Of note, both SAT and VAT EGFR mRNA were significantly associated with adipogenesis and increased during human adipocyte differentiation. In vitro experiments revealed that EGFR, but not ERBB2 and ERBB4, gene knockdown in preadipocytes and in fully differentiated human adipocytes resulted in decreased expression of adipogenic-related genes. ERBB2 gene knockdown also reduced gene expression of fatty acid synthase in fully differentiated adipocytes. In addition, neuregulin 2 (NRG2) mRNA was associated with expression of adipogenic genes in human adipose tissue and adipocytes, and its overexpression increased expression of EGFR and relevant adipogenic genes. Conclusions: This study demonstrates the association between adipose tissue ERBB2 and obesity, confirms the relevance of EGFR on human adipogenesis, and suggests a possible adipogenic role of NRG2.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.biopha.2022.113972
It is part of: Biomedicine & Pharmacotherapy, 2022, vol. 156, num. 113972
URI: http://hdl.handle.net/2445/190755
Related resource: https://doi.org/10.1016/j.biopha.2022.113972
ISSN: 0753-3322
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
726536.pdf1.83 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.